3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer
- PMID: 16380095
- DOI: 10.1016/j.bbrc.2005.12.059
3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer
Abstract
Epidemiological evidences suggest that the progression and promotion of prostate cancer (CaP) can be modulated by diet. Since all men die with prostate cancer rather than of the disease, it is of particular interest to prevent or delay the progression of the disease by chemopreventive strategies. We have been studying the anticancer properties of compounds present in cruciferous vegetables such as indole-3-carbinol (I3C). Diindolylmethane (DIM) is a dimer of I3C that is formed under acidic conditions and unlike I3C is more stable with higher anti-cancer effects. In the present report, we demonstrate that DIM is a potent anti-proliferative agent compared to I3C in the hormone independent DU 145 CaP cells. The anti-prostate cancer effect is mediated by the inhibition of the Akt signal transduction pathway as DIM, in sharp contrast to I3C, induces the downregulation of Akt, p-Akt, and PI3 kinase. DIM also induced a G1 arrest in DU 145 cells by flow cytometry and downstream concurrent inhibition of cell cycle parameters such as cyclin D1, cdk4, and cdk6. Our data suggest a need for further development of DIM, as a chemopreventive agent for CaP, which justifies epidemiological evidences and molecular targets that are determinants for CaP dissemination/progression. The ingestion of DIM may benefit CaP patients and reduce disease recurrence by eliminating micro-metastases that may be present in patients who undergo radical prostatectomy.
Similar articles
-
Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.Oncogene. 2001 May 24;20(23):2927-36. doi: 10.1038/sj.onc.1204365. Oncogene. 2001. PMID: 11420705
-
Synthetic dimer of indole-3-carbinol: second generation diet derived anti-cancer agent in hormone sensitive prostate cancer.Prostate. 2006 Apr 1;66(5):453-62. doi: 10.1002/pros.20350. Prostate. 2006. PMID: 16353249
-
3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease.Biochem Biophys Res Commun. 2005 Nov 25;337(3):1019-25. doi: 10.1016/j.bbrc.2005.09.143. Epub 2005 Oct 3. Biochem Biophys Res Commun. 2005. PMID: 16219298
-
Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer.In Vivo. 2008 Jul-Aug;22(4):441-5. In Vivo. 2008. PMID: 18712169 Review.
-
The natural chemopreventive compound indole-3-carbinol: state of the science.In Vivo. 2006 Mar-Apr;20(2):221-8. In Vivo. 2006. PMID: 16634522 Review.
Cited by
-
Anticancer effects of 3,3'-diindolylmethane are associated with G1 arrest and mitochondria-dependent apoptosis in human nasopharyngeal carcinoma cells.Oncol Lett. 2013 Feb;5(2):655-662. doi: 10.3892/ol.2012.1063. Epub 2012 Dec 5. Oncol Lett. 2013. PMID: 23420395 Free PMC article.
-
3,3'-Diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMs) induce differential mechanisms of survival and death in androgen-dependent and -independent prostate cancer cells.Genes Cancer. 2015 May;6(5-6):265-280. doi: 10.18632/genesandcancer.60. Genes Cancer. 2015. PMID: 26124925 Free PMC article.
-
3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells.Toxicol Appl Pharmacol. 2012 Sep 15;263(3):345-51. doi: 10.1016/j.taap.2012.07.007. Epub 2012 Jul 16. Toxicol Appl Pharmacol. 2012. PMID: 22800507 Free PMC article.
-
Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients.Am J Transl Res. 2016 Jan 15;8(1):166-76. eCollection 2016. Am J Transl Res. 2016. PMID: 27069550 Free PMC article.
-
Metastatic phenotype is regulated by estrogen in thyroid cells.Thyroid. 2010 Jan;20(1):33-41. doi: 10.1089/thy.2009.0296. Thyroid. 2010. PMID: 20067378 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous